315 related articles for article (PubMed ID: 30409257)
1. PET Molecular Imaging in Atypical Parkinsonism.
Xu Z; Arbizu J; Pavese N
Int Rev Neurobiol; 2018; 142():3-36. PubMed ID: 30409257
[TBL] [Abstract][Full Text] [Related]
2. SPECT Molecular Imaging in Atypical Parkinsonism.
Brumberg J; Isaias IU
Int Rev Neurobiol; 2018; 142():37-65. PubMed ID: 30409259
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of an optimized [
Caminiti SP; Alongi P; Majno L; Volontè MA; Cerami C; Gianolli L; Comi G; Perani D
Eur J Neurol; 2017 May; 24(5):687-e26. PubMed ID: 28244178
[TBL] [Abstract][Full Text] [Related]
4. A disease-specific metabolic brain network associated with corticobasal degeneration.
Niethammer M; Tang CC; Feigin A; Allen PJ; Heinen L; Hellwig S; Amtage F; Hanspal E; Vonsattel JP; Poston KL; Meyer PT; Leenders KL; Eidelberg D
Brain; 2014 Nov; 137(Pt 11):3036-46. PubMed ID: 25208922
[TBL] [Abstract][Full Text] [Related]
5. Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses.
Badoud S; Van De Ville D; Nicastro N; Garibotto V; Burkhard PR; Haller S
Neuroimage Clin; 2016; 12():234-40. PubMed ID: 27489771
[TBL] [Abstract][Full Text] [Related]
6. New advances in tau imaging in parkinsonism.
Valli M; Strafella AP
Int Rev Psychiatry; 2017 Dec; 29(6):628-635. PubMed ID: 29206491
[TBL] [Abstract][Full Text] [Related]
7. Structural Imaging in Atypical Parkinsonism.
Heim B; Krismer F; Seppi K
Int Rev Neurobiol; 2018; 142():67-148. PubMed ID: 30409261
[TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal syndromes: PET and SPECT.
Tatsch K
Neuroimaging Clin N Am; 2010 Feb; 20(1):57-68. PubMed ID: 19959018
[TBL] [Abstract][Full Text] [Related]
9. [¹⁸F]FDG-PET is superior to [¹²³I]IBZM-SPECT for the differential diagnosis of parkinsonism.
Hellwig S; Amtage F; Kreft A; Buchert R; Winz OH; Vach W; Spehl TS; Rijntjes M; Hellwig B; Weiller C; Winkler C; Weber WA; Tüscher O; Meyer PT
Neurology; 2012 Sep; 79(13):1314-22. PubMed ID: 22914831
[TBL] [Abstract][Full Text] [Related]
10. A systematic review of lessons learned from PET molecular imaging research in atypical parkinsonism.
Niccolini F; Politis M
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2244-2254. PubMed ID: 27470326
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging in Parkinsonism: The essential for clinical practice and future perspectives.
Horowitz T; Grimaldi S; Azulay JP; Guedj E
Rev Neurol (Paris); 2022 May; 178(5):484-489. PubMed ID: 35527085
[TBL] [Abstract][Full Text] [Related]
12. The utility of FDG-PET in the differential diagnosis of Parkinsonism.
Brajkovic L; Kostic V; Sobic-Saranovic D; Stefanova E; Jecmenica-Lukic M; Jesic A; Stojiljkovic M; Odalovic S; Gallivanone F; Castiglioni I; Radovic B; Trajkovic G; Artiko V
Neurol Res; 2017 Aug; 39(8):675-684. PubMed ID: 28378615
[TBL] [Abstract][Full Text] [Related]
13. The role of molecular imaging in assessing degenerative parkinsonism - an updated review.
Nicastro N; Garibotto V; Burkhard PR
Swiss Med Wkly; 2018; 148():w14621. PubMed ID: 29698545
[TBL] [Abstract][Full Text] [Related]
14. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
[TBL] [Abstract][Full Text] [Related]
15. Progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration.
Fabbrini G; Fabbrini A; Suppa A
Handb Clin Neurol; 2019; 165():155-177. PubMed ID: 31727210
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET Is an Early Predictor of Overall Survival in Suspected Atypical Parkinsonism.
Hellwig S; Frings L; Amtage F; Buchert R; Spehl TS; Rijntjes M; Tüscher O; Weiller C; Weber WA; Vach W; Meyer PT
J Nucl Med; 2015 Oct; 56(10):1541-6. PubMed ID: 26229141
[TBL] [Abstract][Full Text] [Related]
17. [Differential diagnostics of Parkinson's disease with nuclear medicine procedures].
Meyer PT; Amtage F; Hellwig S
Nervenarzt; 2014 Jun; 85(6):680-9. PubMed ID: 24821290
[TBL] [Abstract][Full Text] [Related]
18. Corticobasal degeneration.
Saranza GM; Whitwell JL; Kovacs GG; Lang AE
Int Rev Neurobiol; 2019; 149():87-136. PubMed ID: 31779825
[TBL] [Abstract][Full Text] [Related]
19. Functional MRI in Atypical Parkinsonisms.
Agosta F; Sarasso E; Filippi M
Int Rev Neurobiol; 2018; 142():149-173. PubMed ID: 30409252
[TBL] [Abstract][Full Text] [Related]
20. [Regional cerebral blood flow single photon emission tomography (SPECT) and magnetic resonance imaging (MRI) may be useful in the diagnosis of patients with cortico-basal degeneration, progressive supranuclear palsy and multiple system atrophy].
Lass P; Sławek J; Derejko M; Dubaniewicz M
Neurol Neurochir Pol; 2003; 37 Suppl 5():263-74. PubMed ID: 15098354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
